BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rozengurt E, Eibl G. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. World J Gastroenterol 2019; 25(15): 1797-1816 [PMID: 31057295 DOI: 10.3748/wjg.v25.i15.1797]
URL: https://www.wjgnet.com/1007-9327/full/v25/i15/1797.htm
Number Citing Articles
1
Zihuang Li, Hongli Yang, Ling Ye, Rencui Quan, Meili Chen. Role of exosomal miRNAs in brain metastasis affected by radiotherapyTranslational Neuroscience 2021; 12(1): 127 doi: 10.1515/tnsci-2020-0163
2
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic ReviewCancers 2022; 14(10): 2486 doi: 10.3390/cancers14102486
3
Ling Zhou, Qiaoyun Wang, Han Zhang, Youjie Li, Shuyang Xie, Maolei Xu. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to GemcitabineBiomolecules 2019; 9(10): 620 doi: 10.3390/biom9100620
4
Matthew Hadden, Anubhav Mittal, Jaswinder Samra, Hala Zreiqat, Sumit Sahni, Yogambha Ramaswamy. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188418 doi: 10.1016/j.bbcan.2020.188418
5
Yaroslav Teper, Guido Eibl. Pancreatic Macrophages: Critical Players in Obesity-Promoted Pancreatic CancerCancers 2020; 12(7): 1946 doi: 10.3390/cancers12071946
6
Nikitha Vobugari, Kai Sun. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies2023;  doi: 10.5772/intechopen.110216
7
Enrique Rozengurt, Guido Eibl. Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug ResistanceCancers 2021; 13(20): 5126 doi: 10.3390/cancers13205126
8
Guido Eibl, Enrique Rozengurt. Metformin: review of epidemiology and mechanisms of action in pancreatic cancerCancer and Metastasis Reviews 2021; 40(3): 865 doi: 10.1007/s10555-021-09977-z
9
Qiuping Liu, Xiaomeng Liu, Guanbin Song. The Hippo Pathway: A Master Regulatory Network Important in CancerCells 2021; 10(6): 1416 doi: 10.3390/cells10061416
10
James Sinnett-Smith, Tarique Anwar, Elaine F. Reed, Yaroslav Teper, Guido Eibl, Enrique Rozengurt. Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted TherapyMolecular Cancer Therapeutics 2022; 21(11): 1652 doi: 10.1158/1535-7163.MCT-21-0964
11
Hui-Hua Chang, Guido Eibl. Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal AdenocarcinomaCells 2019; 8(7): 673 doi: 10.3390/cells8070673
12
Francesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, Davide Carlo Ambrosetti, Valentina Sancisi. Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188341 doi: 10.1016/j.bbcan.2020.188341
13
Guido Eibl, Enrique Rozengurt. Obesity and Pancreatic Cancer: Insight into MechanismsCancers 2021; 13(20): 5067 doi: 10.3390/cancers13205067
14
Yang-Yang Wang, Liang Li, Xiu-Jun Liu, Qing-Fang Miao, Yi Li, Meng-Ran Zhang, Yong-Su Zhen. Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancerJournal of Pharmaceutical Analysis 2022; 12(2): 232 doi: 10.1016/j.jpha.2021.07.001
15
Yaroslav Teper, Linda Ye, Richard T. Waldron, Aurelia Lugea, Xiaoying Sun, James Sinnett-Smith, Oscar J. Hines, Stephen J. Pandol, Enrique Rozengurt, Guido Eibl. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D miceScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43498-9
16
Xufeng Tao, Hong Xiang, Yue Pan, Dong Shang, Junchao Guo, Ge Gao, Gary Guishan Xiao. Pancreatitis initiated pancreatic ductal adenocarcinoma: Pathophysiology explaining clinical evidencePharmacological Research 2021; 168: 105595 doi: 10.1016/j.phrs.2021.105595